QDX-28861-07726
3 vaccinations
0 coded responses
11 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 221 / VA
- Registered
- 2021-02-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-02-16
Dose 1 — Pfizer-BioNTech
-
2021-02-18
Registered in v-safe
- 2021-02-18
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-03-02
-
2021-03-15
Dose 2 — Pfizer-BioNTech
-
2021-03-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, Nausea · Be unable to workAdult check-in
- 2021-03-18
- 2021-04-05
-
2021-09-29
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-10-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-16 | Pfizer-BioNTech | |
| 2 | 2021-03-15 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | Flu |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.